Si dont see anything bad from the share consolidation. is that bad? but for the placement that is only mentioned in the AGM --> is this why you think this will take a hit?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%